Abstract. The 
only partly had any effect in the endothelial cell-thyrocyte co-culture experiment. Indomethacin, a cyclooxygenase inhibitor, did not increase the endothelial cells-induced thyrocyte proliferation. Furthermore, the increased proliferative response of thyrocytes stimulated by endothelial cells was not suppressed by heparin. These results suggest that endothelial cells increase thyrocyte proliferation, and that cell contact or extracellular matrix production by endothelial cells may play an important role in the proliferation of thyrocytes.
Thyroid enlargement is one of the most common manifestations of Graves' disease and Hashimoto's thyroiditis, however, the cause of the enlargement is uncertain. In addition to TSH and various anti¬ bodies, several humoral factors, including epider¬ mal growth factors (EGF) (1-3), insulin-like growth factor-I (IGF-I) (4, 5) , fibroblast growth factor (FGF) (2) and interleukin 1 (IL-1) (6) (7) . Proliferation of en¬ dothelial cells in experimental models of thyroid hyperplasia begins earlier than that of thyroid fol¬ licular cells (8) . From (6) . It was reported that fibroblast growth factor (FGF) acted upon mitogenic factors on thyrocytes (2) . It became apparent that endothelial cells were capable of producing IL-1 (14) and basic FGF (15, 16 Leu M3 and CD20, respectively. We also examined the phenotypic characterization of the cell preparations at day 11 of co-culture using a flow cytometer (EPICS-C cell sorter, Coulter Electronics, Hialeah, FL). As shown in (19) , chon¬ drocytes (20) , monocytes (21) , vascular endothelial cells (22) , vascular smooth muscle cells (19) , and human thyrocytes (6) . Endogenous or exogenous prostaglandins inhibit cell proliferation (23 (6) . In the present study, the stimu¬ latory effects of endothelial cells on human thy¬ rocytes was not enhanced in the presence of indo¬ methacin in the endothelial cell-thyrocyte co-cul¬ ture. These data support the idea that IL-1 may not play any role in the stimulatory effect of endo¬ thelial cells on thyrocyte proliferation.
It was reported that FGF is a mitogenic factor on thyrocytes (2) . In the FGF family, two types of polypeptides exist as acidic FGF and basic FGF (17) . Endothelial cells are able to produce basic FGF (14, 15) . The proliferative effect of basic FGF is sup¬ pressed by heparin (17 (24) or irradiated endothelial cells (25) were partially defined as FGF. We could not exclude the possibility that mitomycin C-treated endothelial cells may release basic FGF, resulting in proliferation of human thyrocytes.
Platelet-derived growth factor (PDGF), which is a growth factor for vascular smooth muscle cells and fibroblasts, is known to be produced from endo¬ thelial cells (26) . Fibroblasts are also able to pro¬ duce PDGF (27) . In our study, fibroblasts could not stimulate thyrocyte proliferation and to our knowl¬ edge, PDGF has not been reported to be a growth factor for thyrocytes. Therefore, it seems unlikely that PDGF produced by endothelial cells may act as a growth factor for thyrocytes. There are other hu¬ moral factors which possess growth-promoting ac¬ tivity for thyrocytes, such as EGF (1-3) and IGF-I (4, 5) . Production sites of EGF are widely distrib¬ uted in the human body (28) and production of prostaglandin E2 in thyrocytes is increased by EGF (3) . IGF-I is also reported to be produced from fibroblasts (29) . Our 
